Methylphenidate (nonfiction): Difference between revisions

From Gnomon Chronicles
Jump to navigation Jump to search
(Created page with "'''Methylphenidate''', sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and pipe...")
 
No edit summary
Line 1: Line 1:
'''Methylphenidate''', sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.  
[[File:Methylphenidate.png|250px|thumb|Methylphenidate 2D skeletal diagram.]]'''Methylphenidate''', sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.  


It was first licensed by the U.S. Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity.
It was first licensed by the U.S. Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity.

Revision as of 08:44, 27 June 2016

Methylphenidate 2D skeletal diagram.

Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.

It was first licensed by the U.S. Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity.

Medical use began in 1960; the drug has become increasingly prescribed since the 1990s, when the diagnosis of ADHD became more widely accepted.

In the News

Fiction cross-reference

Nonfiction cross-reference

External links: